Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.

Title

Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.

Creator

Dluzen Dean E; McDermott Janet L

Publisher

Annals of the New York Academy of Sciences

Date

2002
2002-06

Description

In Part 1 of this report, we review data on the effects of estrogen (E), the anti-E tamoxifen (TMX), and testosterone (T) on methamphetamine (METH)-induced neurotoxicity in female and male CD-1 mice. Treatment of gonadectomized females with a physiological regimen of E significantly diminished the amount of striatal dopamine (DA) depletion to METH compared with non-E-treated mice. If these

Subject

*Neurotoxins; *Sex Characteristics; Animals; Biological; Estrogen Antagonists/*pharmacology; Estrogens/*physiology; Female; Humans; Male; Methamphetamine/*toxicity; Mice; Models; Tamoxifen/pharmacology; Testosterone/pharmacology

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

136–156

Volume

965

Citation

Dluzen Dean E; McDermott Janet L, “Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.,” NEOMED Bibliography Database, accessed April 18, 2024, https://neomed.omeka.net/items/show/4488.